Print this Page
E-mail This Page
Anthony J Olszanski, MD, RPh
I believe that the path towards treating any disease is best navigated by thoroughly understanding not only the disease, but also the patient. Good communication between a physician and a patient is especially critical in the treatment of cancer. Each patient has a right to be both respected and heard. In addition, relying on a team of experts to help manage the complexities of treating cancer is essential for success. As a physician, I strive to provide personalized and scientifically sound care to each of my patients.
My medical career started out as a pharmacist, specializing in oncology, where I prepared chemotherapy regimens and studied the effects the body has on drugs (pharmacokinetics). When I went to medical school, it was for the sole purpose of eventually becoming an oncologist. During my hematology/oncology and clinical pharmacology fellowships, I spent a great deal of time in early clinical development, with a goal of finding new effective therapies for patients with cancer. I honed my knowledge of drug discovery by spending five years in the pharmaceutical industry where I led multiple programs aimed at treating patients with cancers that didn’t respond to traditional chemotherapy. Today, my interests include early drug development for all types of cancers, and understanding how each medication may best be used. In addition I specifically focus on the treatment of gastrointestinal malignancies and melanoma.
In many situations, the best medical care a patient with cancer can get is on a clinical trial. These clinical trials offer patients potentially promising new therapies and very close follow up supplied by a team of experts. Fox Chase Cancer Center, with its leading-edge technology and dedicated medical professionals, offers numerous clinical trials and is helping to advance the care of all patients with cancer.
The staff at Fox Chase Cancer Center impressed me with their unified commitment towards reducing the burden of cancer. When you step through the doors at Fox Chase Cancer Center, it is obvious that focusing on the patient is the top priority. I am proud to be a member of the caring community at FCCC, where oncology research and science is tailored and personalized for each patient.
Video
Introductory Video of Dr. Olszanski
Medical Oncology
Director, Clinical Pharmacology
Fox Chase Phase 1 Program
Meet the other members of the
Medical Oncology team.
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497
New patients can request an appointment online or call
215-728-2570.
Appointments for
Returning Patients
For general information, call:
1-888-FOX CHASE (1-888-369-2427).
An oncology certified nurse will assist you.
Clinical Expertise:
Phase 1 trials, gastrointestinal cancer and melanoma
Medical Education:
Biostatistics, Dartmouth Medical School Center for Evaluative Clinical Sciences, Hanover, NH 2003;
MD, University of Medicine and Dentistry of New Jersey, Newark, NJ, 1996
BS Pharmacy, University of Montana, Missoula, MT, 1990
Residency:
Internal Medicine, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 1996-1999
Fellowships:
Clinical Pharmacology/Toxicology Fellowship, Oncology Phase I Program, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 2002-2004;
Hematology/Oncology Fellowship, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 1999-2002
Certifications:
Medical Oncology
Clinical Pharmacology
Internal Medicine
Professional Societies:
American Society of Clinical Oncology;
American Board
of Clinical Pharmacology
Research Interests:
Early clinical drug discovery trials (phase 1 trials)